Results 21 to 30 of about 93,036 (258)
Chronochemistry in neurodegeneration [PDF]
The problem of distinguishing causes from effects is not a trivial one, as illustrated by the science fiction writer Isaac Asimov in a novel dedicated to an imaginary compound with surprising "chronochemistry" properties. The problem is particularly important when trying to establish the etiology of diseases.
Pastore Annalisa, Adinolfi Salvatore
openaire +5 more sources
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins [PDF]
An expanded GGGGCC repeat in C9orf72 is the most common genetic cause of frontotemporal dementia and amyotrophic lateral sclerosis. A fundamental question is whether toxicity is driven by the repeat RNA itself and/or by dipeptide repeat proteins ...
Ridler, CE +61 more
core +1 more source
Transglutaminases and neurodegeneration [PDF]
AbstractTransglutaminases (TGs) are Ca2+‐dependent enzymes that catalyze a variety of modifications of glutaminyl (Q) residues. In the brain, these modifications include the covalent attachment of a number of amine‐bearing compounds, including lysyl (K) residues and polyamines, which serve to either regulate enzyme activity or attach the TG substrates ...
Thomas M, Jeitner +4 more
openaire +2 more sources
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration [PDF]
Background Epidemiological and molecular findings suggest a relationship between Alzheimer’s disease (AD) and dyslipidemia, although the nature of this association is not well understood ...
McEvoy, LK +23 more
core +1 more source
AbstractFirst identified in 1975, tau was implicated in Alzheimer's disease 10 years later. Filamentous tangle inclusions were known to be made of hyperphosphorylated tau by 1991, with similar inclusions gaining recognition for being associated with other neurodegenerative diseases. In 1998, mutations in MAPT, the gene that encodes tau, were identified
Goedert, Michel +3 more
openaire +2 more sources
Neurodegeneration: New Road Leads Back to the Synapse [PDF]
Much of Parkinson’s research over the last decade has focused on cellular stress as a candidate mechanism. In this issue of Neuron, a new study by Matta et al.
Heutink, Peter +3 more
core +1 more source
Ecstasy and neurodegeneration [PDF]
Publicity in the popular press and medical journals1 on the dangers of using ecstasy (3,4-methylenedioxymethamphetamine) has concentrated almost exclusively on the problems of acute toxicity. While the unnecessary death of any young person is rightly deplored, it is strange that so little attention is being paid to the long term effects of this ...
A R, Green, G M, Goodwin
openaire +2 more sources
Striatal neuroinflammation promotes parkinsonism in rats [PDF]
The specific role of neuroinflammation in the pathogenesis of Parkinson's disease remains to be fully elucidated. By infusing lipopolysaccharide (LPS) into the striatum, we investigated the effect of neuroinflammation on the dopamine nigrostriatal ...
Randy L Hunter +24 more
core +2 more sources
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based biomarker for Alzheimer's disease (AD) diagnosis and prognostication.
core +1 more source
While transcripts of neuronal mitochondrial genes are strongly suppressed in central nervous system inflammation, it is unknown whether this results in mitochondrial dysfunction and whether an increase of mitochondrial function can rescue ...
Roth, Vanessa +16 more
core +1 more source

